原子加速器官网3.2正式版-hammer加速器

Please note not all percentages of capital raised outlined above were raised through the Capital Cell website itself.

原子加速器官网3.2正式版-hammer加速器

超级微皮恩安卓破解版
超级微皮恩安卓破解版
Capital Cell, for the love of
science
innovation

PROFITABILITY COMPARISON

Source: The UK Life Sciences Industry and the Public Markets, 2016/17 report, by BIA (Biotech Industry Association)

All UK companies: 7%

All companies operating in the UK healthcare sector: 16%

Small and growing healthcare companies on the UK Alternative Investment Market: 48%

原子加速器官网3.2正式版-hammer加速器

We are working with a number of fantastic European partners to improve the quality of our service to both investors and companies seeking funding.

原子加速器官网3.2正式版-hammer加速器

Each start up is different and we’ll treat you as an individual.
Share your pitch deck with us and you’ll receive a bespoke funding proposal, an analytical report with detailed feedback and personalised recommendations to help you successfully raise the funds you need.

Share your pitch deck